Innoviva INVA
NASDAQ INVA
$20.66 -0.40 (-1.90%)
At close: Oct 23, 2026 · 4:00 PM EDT

Innoviva (INVA) Sale and Maturity of Investments (2010 - 2026)

Updated

Analysis

Innoviva (INVA) Sale and Maturity of Investments (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Innoviva 1.50 Bn -790.08 Mn 90.62 Mn 818,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 818,000.00
Mar 31, 2026 43.29 Mn
Dec 31, 2025 8.23 Mn
Mar 31, 2025 19.94 Mn
Dec 31, 2024 22.93 Mn
Sep 30, 2024 46.86 Mn
Jun 30, 2024 634,000.00
Mar 31, 2024 5.34 Mn
Jun 30, 2023 1.19 Mn
Mar 31, 2023 1.29 Mn
Mar 31, 2022 24.28 Mn
Dec 31, 2021 14,000.00
Sep 30, 2021 2.88 Mn
Jun 30, 2021 16.16 Mn
Mar 31, 2021 2.39 Mn
Sep 30, 2020 4.00 Mn
Jun 30, 2020 28.00 Mn
Mar 31, 2020 54.00 Mn
Dec 31, 2019 53.00 Mn
Sep 30, 2019 103.05 Mn
API Access

Innoviva Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=INVA&period=max&api_key=YOUR_API_KEY